Citations

Mayo Clinic

Showing 10 of 108522 citations.

Presentation, surgical outcome, and supplementary motor area syndrome risk of posterior superior frontal gyrus tumors
Jusué-Torres, Ignacio , White, Jaclyn J., Bouchal, Samantha M. , Hsu, Andrea R. , Ha, Yooree , Pumford, Andrew D. , Hong, Sukwoo , Riviere-Cazaux, Cécile , Wang, Kimberly , Helal, Ahmed , Brown, Desmond A., Jusue-Torres, Ignacio , Bouchal, Samantha M , Bauman, Megan M. J. , Brown, Desmond , Parney, Ian F.

Journal of Neurosurgery | August 31, 2024 | Volume: No volume available | Issue: No issue available | Pages: 1-12

10.3171/2024.5.jns231850 | PMID 39213666 Get It

OBJECTIVE Following resection of posterior superior frontal gyrus (PSFG) tumors, patients can experience supplementary motor area (SMA) syndrome consisting of contralateral hemiapraxia and/or speech apraxia. Given the heterogeneity of PSFG tumors, the authors sought to determine the risk of postoperative deficits and assess predictors of outcomes for all intraparenchymal PSFG tumors undergoing surgery (biopsy or resection), regardless of histology. METHODS This was a retrospective single-center cohort study of adult PSFG-region tumors undergoing biopsy or resection by a single surgeon. RESULTS A total of 106 consecutive patients undergoing 123 procedures (21 biopsies, 102 resections) fulfilled inclusion and exclusion criteria. Anaplastic astrocytomas were the most frequent among resected tumors (39% vs 29%), while glioblastomas were most common among biopsies (38% vs 27%) (p < 0.0001). The biopsy cohort was more likely to have tumor involvement outside the PSFG (90% vs 62%) (p = 0.011), most commonly in the motor cortex (67% vs 31%) (p = 0.005). Seizures were the most common presenting symptom in the resection cohort (p = 0.017), while motor deficits were more common in the biopsy cohort (58% vs 29%) (p < 0.001). Immediate postoperative neurological deficits occurred in 71 cases (58%), but only 3 of the deficits were permanent at 6 months of follow-up (2%). Postoperative SMA syndrome occurred in 48 cases (47%) and was significantly associated with involvement of the motor cortex (p = 0.018) or cingulate gyrus (p = 0.023), which were also significant in multivariate analysis as risk factors for SMA syndrome. However, postoperative SMA syndrome was not significantly associated with overall survival (p = 0.51). There were no perioperative deaths, but corpus callosum involvement (p < 0.001), contrast enhancement (p = 0.003), and glioblastoma pathology (p = 0.038) predicted worse overall survival in patients undergoing resection. CONCLUSIONS Nearly half of all patients undergoing resection of PSFG-region tumors experience a postoperative SMA syndrome. Individuals with corpus callosum and/or motor cortex involvement may be at an increased risk of experiencing SMA syndrome. However, these deficits are usually transient, and the risk of permanent new deficits is very low (3%). Preoperative characteristics including corpus callosum involvement and tumor enhancement—in addition to pathology—might serve as predictors of overall survival within this patient population.
Functional mapping of movement and speech using task-based electrophysiological changes in stereoelectroencephalography
Fine, Anthony L. , Kerezoudis, Panagiotis , Alden, Eva , Miller, Kai J. , Fine, Anthony , Jensen, Michael A. , Wong‐Kisiel, Lily C. , Hermes, Dora

Journal of Neurosurgery | August 30, 2024 | Volume: 142 | Issue: 2 | Pages: 311-323

10.3171/2024.5.jns24434 | PMID 39213665 Get It

OBJECTIVE Stereoelectroencephalography (SEEG) has become the predominant method for intracranial seizure localization. When imaging, semiology, and scalp EEG findings are not in full agreement or definitively localizing, implanted SEEG recordings are used to test candidate seizure onset zones (SOZs). Discovered SOZs may then be targeted for resection, laser ablation, or neurostimulation. If an SOZ is eloquent, resection and ablation are both contraindicated, so identifying functional representation is crucial for therapeutic decision-making. The authors present a novel functional brain mapping technique that utilizes task-based electrophysiological changes in SEEG during behavioral tasks and test this in pediatric and adult patients. METHODS SEEG was recorded in 20 patients with epilepsy who ranged in age from 6 to 39 years (12 female, 18 of 20 patients < 21 years of age) and underwent implanted monitoring to identify seizure onset. Each performed 1) visually cued simple repetitive movements of the hand, foot, or tongue while electromyography was recorded; and 2) simple picture-naming or verb-generation speech tasks while audio was recorded. Broadband changes in the power spectrum of the SEEG recording were compared between behavior and rest. RESULTS Electrophysiological functional mapping of movement and/or speech areas was completed in all 20 patients. Eloquent representation was identified in both cortex and white matter and generally corresponded to classically described functional anatomical organization as well as other clinical mapping results. Robust maps of brain activity were identified in healthy brain, regions of developmental or acquired structural abnormality, and SOZs. CONCLUSIONS Task-based electrophysiological mapping using broadband changes in the SEEG signal reliably identifies movement and speech representation in pediatric and adult epilepsy patients.
Evaluation of prognostic factors in patients with high-risk classical Hodgkin lymphoma undergoing autologous transplantation
Huang, Ying , Cashen, Amanda F. , Vaughn, John L, Badar, Talha , Sethi, Tarsheen , Reddy, Nishitha , Bello, Celeste, Kothari, Shalin , Hernandez‐Ilizaliturri, Francisco J. , Svoboda, Jakub , Glenn, Martha, Cohen, Jonathon B. , Sorge, Caryn, Christian, Beth , Herrera, Alex F. , Vaughn, John L. , Epperla, Narendranath , Badar, Talha , Karmali, Reem , Cohen, Jonathon B , Herrera, Alex F , Hamadani, Mehdi , Costa, Luciano J , Xavier, Ana C , Epperla, Narendranath , Hanel, Walter G. , Barta, Stefan K , Caimi, Paolo F. , Karmali, Reem , Chavez, Julio C , Lansigan, Frederick , Hamadani, Mehdi , Costa, Luciano J.

Blood Advances | August 30, 2024 | Volume: 8 | Issue: 21 | Pages: 5458-5466

10.1182/bloodadvances.2024013743 | PMID 39213424 Get It

Abstract There are limited data assessing the risk scores for primary treatment failure (PTF) in patients with classical Hodgkin lymphoma (cHL; PTF-cHL) undergoing autologous hematopoietic cell transplantation (auto-HCT). ECLIPSE (Evaluation of Classical Hodgkin Lymphoma patients wIth Primary treatment failure and analySis of outcomEs) is a multicenter retrospective cohort of patients with PTF-cHL (aged ≥15 years) diagnosed on or after 1 January 2005, at 15 US medical centers. PTF was defined as 1 of the following patterns of failure: (1) progressive disease by imaging during or within 6 weeks of completion of frontline chemotherapy (primary progression [PP]); (2) partial response (PR) or stable disease (SD) by imaging after completion of frontline treatment (PR/SD); (3) progression of disease by imaging (and confirmed by biopsy) within 12 months of frontline therapy completion after prior documentation of complete response (CR; early relapse [ER]). A total of 478 patients were included in the analysis. Among these, 217 (45%) were PP, 86 (18%) were PR/SD, and 175 (37%) were ER. The 6-month and 1-year cumulative incidence of nonrelapse mortality after auto-HCT were 0.9% and 1.1%, respectively. The median progression-free survival (PFS) and overall survival (OS) after auto-HCT were 4.33 and 10.09 years, respectively. Although those not in CR at the time of auto-HCT were associated with inferior PFS and OS, advanced age and diagnosis before 2011 were associated with inferior OS. This study showcases the safety and long-term efficacy of auto-HCT, even in patients with high-risk disease who are traditionally considered chemotherapy refractory, and will serve as a benchmark for the ongoing transplant vs no transplant trials.
Extracorporeal Membrane Oxygenation-Supported Patient Outcome Undergoing Transcatheter Aortic Valve Replacement
Banga, Akshat , Bansal, Vikas , Pattnaik, Harsha , Amal, Tanya , Agarwal, Anjali , Bansal, Vikas , Pattnaik, Harsha , Guru, Pramod

ASAIO Journal | August 30, 2024 | Volume: 70 | Issue: 11 | Pages: 920-928

10.1097/mat.0000000000002305 | PMID 39213414 Get It

The efficacy and safety of extracorporeal membrane oxygenation (ECMO) support during transcatheter aortic valve replacement (TAVR) remains unknown. We conducted a meta-analysis to compare benefit and risk of ECMO in TAVR patients. Bibliographic databases were searched from inception to January 1, 2024. Included studies involved patients ≥18 years old undergoing TAVR and using ECMO emergently or prophylactically. Mortality and procedure success were primary outcomes. Peri- or postoperative complications were the secondary outcomes. We identified 11 observational studies, including 2,275 participants (415 ECMO and 1,860 non-ECMO). The unadjusted mortality risk in ECMO-supported patient was higher than non-ECMO patients (odds ratio [OR] 1.73). The mortality unadjusted risk remained high (OR 3.89) and statistically significant for prophylactic ECMO. Prophylactic ECMO had lower mortality risk compared with emergent ECMO (OR 0.17). Extracorporeal membrane oxygenation-supported patients had lower procedural success rate (OR 0.10). Extracorporeal membrane oxygenation patients undergoing TAVR had significantly increased risk of bleeding (OR 3.32), renal failure (OR 2.38), postoperative myocardial infarction (OR 1.89), and stroke (OR 2.32) compared with non-ECMO patients. Clinical results are not improved by ECMO support in patients with high-risk TAVR. Prophylactic ECMO outperforms emergent. Overall, ECMO support increases mortality and postoperative complications. Transcatheter aortic valve replacement outcomes may improve with prophylactic ECMO in high-risk situations.
Deep Learning in Automating Breast Cancer Diagnosis from Microscopy Images
Gu, Qiangqiang , Prodduturi, Naresh, Hart, Steven N.

2024 Design of Medical Devices Conference | August 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1115/dmd2024-1017 Get It

Abstract Breast cancer is one of the most common cancers in women. With early diagnosis, some breast cancers are highly curable. Classifying normal versus tumor breast tissues from microscopy images is an ideal case to use for deep learning and could help diagnose breast cancer with higher reproducibility. Since data preprocessing and hyperparameter tuning have impacts on breast cancer classification accuracies, training a classifier with appropriate data preprocessing and optimized hyperparameters could improve breast cancer classification accuracy. Using 12 combinations of model architectures, data preprocessing, and hyperparameter configurations, the validation accuracy was calculated using the BreAst Cancer Histology (BACH) dataset. The DenseNet201, a non-specialized model architecture, with transfer learning approach achieved 98.61% validation accuracy compared to only 64.00% for the digital pathology (DP)-specialized model architecture. The combination of image data preprocessing and hyperparameters have a profound impact on the performance of deep neural networks for image classification. To identify a well-performing neural network to classify tumor versus normal breast histology, researchers should not only focus on developing new models specifically for DP, since hyperparameter tuning for existing deep neural networks in the computer vision field could also achieve a better prediction accuracy.
Efficacy and Safety of Interleukin-12/23 and Interleukin-23 Inhibitors for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Jaber, Fouad , Alsakarneh, Saqr , Alsharaeh, Tala , Salahat, Ahmed-Jordan, Jaber, Mohammad, Gangwani, Manesh Kumar , Kilani, Yassine , Alsakarneh, Saqr G , Ayyad, Mohammed , Abboud, Yazan , Mohamed, Islam , Ali, Hassam , Farraye, Francis A. , Hashash, Jana G.

American Journal of Therapeutics | August 30, 2024 | Volume: 32 | Issue: 1 | Pages: e17-e29

10.1097/mjt.0000000000001766 | PMID 39212744 Get It

Background: Targeting interleukin-23 (IL-23) represents a significant therapeutic avenue for treating ulcerative colitis (UC). Study Question: What are the effectiveness and safety of selective inhibitors targeting IL-23p19 and IL-12/23p40 in individuals with moderate-to-severe UC? Data Sources: MEDLINE, Embase, Scopus, and Cochrane databases. Study Design: A systematic search of MEDLINE, Embase, Scopus, and Cochrane databases till January 15, 2024, to identify randomized controlled trials comparing IL-23p19 and IL-12/23p40 inhibitors against placebo or active comparators in UC patients. The primary outcome was clinical remission, with secondary outcomes including clinical response, endoscopic remission, and safety profiles during induction and maintenance phases. Using a fixed-effect model, we pooled dichotomous data with risk ratio (RR) and 95% confidence interval (CI) for analysis. Results: In 5 trials involving 1120 patients with moderate to severe UC, targeting IL-23 showed significant superiority in inducing clinical remission [RR: 2.08, 95% CI, (1.66–2.61)], endoscopic remission [RR: 1.73, 95% CI, (1.39–2.16)], and histologic remission [RR: 1.88, 95% CI, (1.34–2.64)]. Additionally, individuals treated with IL-12/23p40 or IL-23p19 antagonists maintained clinical remission [RR: 1.85, 95% CI, (1.53–2.23)], endoscopic remission [RR: 2.03, 95% CI, (1.60–2.57)], and histologic remission [RR: 1.66, 95% CI, (1.11–2.48)]. Targeting IL-23 was linked with a reduced risk of any adverse events (AE) during both induction [RR: 0.94, 95% CI, (0.86–1.02)] and maintenance phases [RR: 0.93, 95% CI, (0.86–0.99)], any serious AE during the induction phase [RR: 0.53, 95% CI, (0.36–0.78)], and withdrawal due to AEs compared to patients receiving placebo during induction [RR: 0.24, 95% CI (0.14, 0.43)]. Conclusion: Targeting IL-23 demonstrates efficacy and safety for inducing and maintaining clinical and endoscopic remission in moderate-to-severe UC patients.
Sharing Consumer Health Information in Florida: Understanding Challenges to Navigating Health Care Library Organization Collaboration
Brigham, Tara , Haver, Mary Katherine , Novak, Angie , Ansell, Margaret , Perez, Jorge E. , Walther, James H., Brigham, T J

Journal of Hospital Librarianship | August 30, 2024 | Volume: 24 | Issue: 4 | Pages: 315-324

10.1080/15323269.2024.2395766 Get It

Population-Based Incidence and Clinical Characteristics of Ocular Adnexal Tumors in Olmsted County, Minnesota
Wang, Kenny Y. , Xu, Timothy T. , Oyemade, Kafayat A. , Dominguez, Johanny Lopez , Hodge, David O. , White, Launia J. , Tooley, Andrea A. , Dumbrava, Mihai G, Lopez Dominguez, Johanny, Dumbravă, Mihai , Dalvin, Lauren A.

Ophthalmic Epidemiology | August 30, 2024 | Volume: 32 | Issue: 3 | Pages: 326-333

10.1080/09286586.2024.2379971 | PMID 39212488 Get It

Flow diverter braid deformation following treatment of cerebral aneurysms: incidence, clinical relevance, and potential risk factors
Popica, Dan Adrian , Cortese, Jonathan , Oliver, Alexander A , Plaforet, Vincent, Diaz, Ignacio Molina, Ikka, Léon , Mihalea, Cristian , Chalumeau, Vanessa , Kallmes, David F. , Caroff, Jildaz , Mihalea, Cristian , Chalumeau, Vanessa , Caroff, Jildaz , Spelle, Laurent , Cortese, Jonathan , Oliver, Alexander A , Rodriguez‐Erazú, Fernanda , Spelle, Laurent

Journal of NeuroInterventional Surgery | August 30, 2024 | Volume: 17 | Issue: 8 | Pages: 864-869

10.1136/jnis-2024-022236 | PMID 39214688 Get It

Background Although flow diverters (FDs) have benefited from several technical improvements, recently concerns have arisen regarding the braid stability after implantation. Thus, we investigated frequency, predictive factors, and clinical impact of the phenomenon of FD braid deformation (FDBD). Methods Consecutive intracranial aneurysms (IAs) treated with various FDs, between January 2018 and July 2023, were reviewed to identify FDBD (defined as the deformation of a FD without any external force applied to it). Patient, aneurysm, procedural, and FD characteristics were retrieved and analyzed using univariate and multivariable analyses. Morbidity is defined as a score of +1 in the modified Rankin Scale at 3 months. Results In total, 245 FD procedures (271 FDs implanted; 25 multiple IAs treated with 1 FD) in 228 patients; FDBD was observed in 36/245 cases (14.7%), mainly at follow-up angiography (32/36, 88.9%); fish-mouthing was the most frequent FDBD. Morbidity was related to fish-mouthing and braid collapse and was significantly higher in the FDBD group after retreatment (p=0.04). Drawn filled tubing with platinum (DFT) (adjusted odds ratio (aOR)=7.0, 95% CI 3.0 to 17.5; p<0.001) and FD diameter (aOR=2.2, 95% CI 1.3 to 4.1; p<0.01) were identified as independent predictors of FDBD. The metal alloy composing the FD (p=0.13) and coated surfaces were not significantly associated with FDBD (p=0.54 in multivariable analysis). Conclusions FDBD is a frequent phenomenon observed in about 15% of cases, and it was responsible for higher morbidity. Only FD characteristics (DFT and FD diameter) were independent determinants of FDBD. Future research should focus on the impact of novel braid configurations and materials on braid stability.
Narrative or systematic? A decision-making guide on selecting type of review: an infographic
D’Souza, Ryan S. , Kelley, George A. , D'Souza, Ryan S

Regional Anesthesia & Pain Medicine | August 30, 2024 | Volume: 50 | Issue: 12 | Pages: 981-981

10.1136/rapm-2024-105956 | PMID 39214625 Get It